Cargando…

Therapeutic apheresis in autoimmune diseases

Systemic autoimmune diseases based on an immune pathogenesis produce autoantibodies and circulating immune complexes, which cause inflammation in the tissues of various organs. In most cases, these diseases have a bad prognosis without treatment. Therapeutic apheresis in combination with immunosuppr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bambauer, Rolf, Latza, Reinhard, Bambauer, Carolin, Burgard, Daniel, Schiel, Ralf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074795/ https://www.ncbi.nlm.nih.gov/pubmed/27790028 http://dx.doi.org/10.2147/OARRR.S34616

Ejemplares similares

LDL-Apheresis: Technical and Clinical Aspects
por: Bambauer, Rolf, et al.
Publicado: (2012)

Surface-Treated versus Untreated Large-Bore Catheters as Vascular Access in Hemodialysis and Apheresis Treatments
por: Bambauer, Rolf, et al.
Publicado: (2012)

Apheresis in Autoimmune Encephalitis and Autoimmune Dementia
por: Rössling, Rosa, et al.
Publicado: (2020)

Principles of Therapeutic Apheresis in Neurological Disease
por: Strasser, Erwin
Publicado: (2023)

Analysis of α- and β-amanitin in Human Plasma at Subnanogram per Milliliter Levels by Reversed Phase Ultra-High Performance Liquid Chromatography Coupled to Orbitrap Mass Spectrometry
por: Bambauer, Thomas P., et al.
Publicado: (2020)

Surface topologies and self interactions in reactive and nonreactive Richtmyer–Meshkov instability
por: Bambauer, Maximilian, et al.
Publicado: (2023)

Therapeutic apheresis in kidney diseases: an updated review
por: Chen, Yi-Yuan, et al.
Publicado: (2022)

Therapeutic apheresis in kidney transplantation: An updated review
por: Salvadori, Maurizio, et al.
Publicado: (2019)

Therapeutic Apheresis in Metabolic Syndrome
por: Voinov, V.A.
Publicado: (2018)

Safety of Therapeutic Apheresis in Children and Adolescents
por: Taylan, Christina, et al.
Publicado: (2022)

Role of therapeutic apheresis and phlebotomy techniques in anaesthesia and critical care
por: Bose, Neeta, et al.
Publicado: (2014)

Therapeutic apheresis in peripheral and retinal circulatory disorders
por: Ramunni, Alfonso, et al.
Publicado: (2012)

Polyzwitterionic Coating of Porous Adsorbents for Therapeutic Apheresis
por: Semak, Vladislav, et al.
Publicado: (2022)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease
por: Yasmin, Farah, et al.
Publicado: (2022)

LDL Apheresis and Lp (a) Apheresis: A Clinician’s Perspective
por: Kayikcioglu, Meral
Publicado: (2021)

An update on lipid apheresis for familial hypercholesterolemia
por: Taylan, Christina, et al.
Publicado: (2022)

Apheresis in Neurological Disorders
por: Dorst, Johannes
Publicado: (2020)

Apheresis and Covid-19
por: Griveas, Ioannis
Publicado: (2022)

Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years
por: Filip, Stanislav, et al.
Publicado: (2020)

Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions
por: Kleiter, Ingo, et al.
Publicado: (2018)

Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs—A Systematic Review
por: Rolfes, Leoni, et al.
Publicado: (2019)

Use of granulocyte and monocyte adsorption apheresis in dermatology (Review)
por: Gnesotto, Laura, et al.
Publicado: (2022)

A loxoscelism case received therapeutic apheresis and hyperbaric oxygen therapy
por: Cetinkaya, Ali, et al.
Publicado: (2020)

Current Role of Lipoprotein Apheresis
por: Thompson, Gilbert, et al.
Publicado: (2019)

Beneficial effect of LDL-apheresis in refractory nephrotic syndrome
por: Muso, Eri
Publicado: (2014)

Current Role of Lipoprotein Apheresis in the Treatment of High-Risk Patients
por: Julius, Ulrich
Publicado: (2018)

Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future
por: Chen, Xiu-Li, et al.
Publicado: (2020)

Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis
por: Berger, Benjamin, et al.
Publicado: (2015)

Reimbursement for therapeutic apheresis devices and procedures for using the healthcare insurance system in Japan
por: Kusaoi, Makio, et al.
Publicado: (2020)

Therapeutic apheresis within immune-mediated neurological disorders: dosing and its effectiveness
por: Klingele, Matthias, et al.
Publicado: (2020)

Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy
por: Colpo, A., et al.
Publicado: (2020)

Proposal of the Need for New Korean Guidelines on the Use of Therapeutic Apheresis in Clinical Practice
por: Chung, Yousun, et al.
Publicado: (2022)

Role of lipid apheresis in changing times
por: Schuff-Werner, Peter, et al.
Publicado: (2012)

Leukocyte Apheresis in the Management of Ulcerative Colitis
por: Helmy, Ahmed, et al.
Publicado: (2009)

Hyperlipoproteinaemia(a) – apheresis and emerging therapies
por: Vogt, Anja
Publicado: (2017)

Two acute psychiatric emergencies and prevalence of mental health disorders at an outpatient apheresis clinic: Implications for apheresis practitioners
por: Williams, Shelly M., et al.
Publicado: (2022)

Lipoprotein(a) Lowering—From Lipoprotein Apheresis to Antisense Oligonucleotide Approach
por: Greco, Maria Francesca, et al.
Publicado: (2020)

Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons
por: Torzewski, Jan, et al.
Publicado: (2022)

Nurses perspective of apheresis in SARS-CoV-2 infected patients
por: Tjoelker, Linda, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4f58mh6lg2oe7ocn2h5p7q0ccd